These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8434702)

  • 1. Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking.
    Westra WH; Offerhaus GJ; Goodman SN; Slebos RJ; Polak M; Baas IO; Rodenhuis S; Hruban RH
    Am J Surg Pathol; 1993 Mar; 17(3):213-20. PubMed ID: 8434702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
    Sarkar FH; Li Y; Vallyathan V
    Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung.
    Westra WH; Slebos RJ; Offerhaus GJ; Goodman SN; Evers SG; Kensler TW; Askin FB; Rodenhuis S; Hruban RH
    Cancer; 1993 Jul; 72(2):432-8. PubMed ID: 8319174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and significance of tumoral suppressor p53 gene in lung adenocarcinomas.
    Cornianu M; Tudose N; Potencz E; Lazăr E
    Rom J Morphol Embryol; 1996; 42(1-2):73-82. PubMed ID: 9038389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.
    Marchetti A; Pellegrini S; Sozzi G; Bertacca G; Gaeta P; Buttitta F; Carnicelli V; Griseri P; Chella A; Angeletti CA; Pierotti M; Bevilacqua G
    Br J Cancer; 1998 Jul; 78(1):73-8. PubMed ID: 9662254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension.
    Lin MW; Wu CT; Shih JY; Chang YL; Yang PC
    J Surg Oncol; 2014 Aug; 110(2):99-106. PubMed ID: 24788590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of p53 protein in adenocarcinoma of the pancreas.
    DiGiuseppe JA; Hruban RH; Goodman SN; Polak M; van den Berg FM; Allison DC; Cameron JL; Offerhaus GJ
    Am J Clin Pathol; 1994 Jun; 101(6):684-8. PubMed ID: 8209852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic analysis of k-ras, p53, and ERBB-2 gene alterations in pulmonary adenocarcinoma.
    Visscher DW; Yadrandji S; Tabaczka P; Kraut M; Sarkar FH
    Diagn Mol Pathol; 1997 Feb; 6(1):64-9. PubMed ID: 9028739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2E1 polymorphism, cigarette smoking, p53 expression, and survival in non-small cell lung cancer: a long term follow-up study.
    Haque AK; Au W; Cajas-Salazar N; Khan S; Ginzel AW; Jones DV; Zwischenberger JB; Xie J
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):315-22. PubMed ID: 15536330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 and K-ras mutations in lung cancers from former and never-smoking women.
    Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
    Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low frequency of alterations in p53, K-ras, and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black.
    Swafford DS; Nikula KJ; Mitchell CE; Belinsky SA
    Carcinogenesis; 1995 May; 16(5):1215-21. PubMed ID: 7539340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.
    Huang CL; Taki T; Adachi M; Konishi T; Higashiyama M; Kinoshita M; Hadama T; Miyake M
    Int J Oncol; 1998 Mar; 12(3):553-63. PubMed ID: 9472092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.
    Slebos RJ; Hruban RH; Dalesio O; Mooi WJ; Offerhaus GJ; Rodenhuis S
    J Natl Cancer Inst; 1991 Jul; 83(14):1024-7. PubMed ID: 2072410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of p16 homozygous deletions with clinicopathologic characteristics and EGFR/KRAS/p53 mutations in lung adenocarcinoma.
    Iwakawa R; Kohno T; Anami Y; Noguchi M; Suzuki K; Matsuno Y; Mishima K; Nishikawa R; Tashiro F; Yokota J
    Clin Cancer Res; 2008 Jun; 14(12):3746-53. PubMed ID: 18559592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Bcl-2 and mutations in p53 and K-ras in resected human non-small cell lung cancers.
    Kitagawa Y; Wong F; Lo P; Elliott M; Verburgt LM; Hogg JC; Daya M
    Am J Respir Cell Mol Biol; 1996 Jul; 15(1):45-54. PubMed ID: 8679221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.